Sorafenib and Vorinostat Kill Colon Cancer Cells by CD95-Dependent and -Independent Mechanisms

Podobne knjige/članki

• Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation
  od: Zhang, Guo, et al.
  Izdano: (2008)
• Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation
  od: Park, Margaret A., et al.
  Izdano: (2008)
• Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca2+ - de novo ceramide - PP2A - ROS dependent signaling pathway
  od: Park, Margaret A., et al.
  Izdano: (2010)
• 17AAG and MEK1/2 inhibitors kill GI tumor cells via Ca(2+)-dependent suppression of GRP78/BiP and induction of ceramide and ROS
  od: Walker, Teneille, et al.
  Izdano: (2010)
• BCL-2 Family Inhibitors Enhance Histone Deacetylase Inhibitor and Sorafenib Lethality via Autophagy and Overcome Blockade of the Extrinsic Pathway to Facilitate Killing
  od: Martin, Aditi Pandya, et al.
  Izdano: (2009)